“On September 6, 2023, the Drugs Controller General of India issued an advisory, referring to a safety alert issued by the WHO for falsified product Defitelio (Defibrotide) 80 mg/ml concentrate for solution for infusion, manufactured by Gentium Srl. Photo: cdsco.gov.in”